-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $475

Benzinga·07/14/2026 11:54:33
语音播报
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $510 to $475.